Reshma Rangwala
Chief Tech/Sci/R&D Officer bij KARYOPHARM THERAPEUTICS INC.
Vermogen: 405 675 $ op 29-02-2024
Profiel
Presently, Reshma Rangwala occupies the position of Chief Medical Officer & Executive Vice President at Karyopharm Therapeutics, Inc.
She previously occupied the position of Executive Clinical Director at Merck & Co., Inc., Chief Medical Officer of Aravive, Inc. and Vice President-Medical at Genmab, Inc.
She received an undergraduate degree from Duke University and a doctorate from The University of Cincinnati College of Medicine.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-03-2024 | 349 720 ( 0.31% ) | 405 675 $ | 29-02-2024 |
Actieve functies van Reshma Rangwala
Bedrijven | Functie | Begin |
---|---|---|
KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01-04-2022 |
Eerdere bekende functies van Reshma Rangwala
Bedrijven | Functie | Einde |
---|---|---|
ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 28-03-2022 |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 01-07-2020 |
MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01-05-2017 |
Opleiding van Reshma Rangwala
Duke University | Undergraduate Degree |
The University of Cincinnati College of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
KARYOPHARM THERAPEUTICS INC. | Health Technology |
ARAVIVE, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |